Sotuvning sof marjinal rentabelligi: Lucid Diagnostics, Inc (LUCD)

Lucid Diagnostics Inc (LUCD) korporativ emblemasi va logotipi

Biomateriallarning laboratoriyalarga optimallashtirilgan yetkazib berilishi Lucid Diagnostics Inc. (LUCD) kompaniyasining o'sish dinamikasini qo'llab-quvvatlaydi. Haqiqiy sof foyda marjasi joriy tendentsiyani aks ettiradi, bunda -1127.20 ushbu parametr darajasini belgilaydi. Lucid Diagnostics Inc. (LUCD) DNA yig'ish uchun noyob sharcha kapsulasidan foydalangan holda, GERD bilan kasallangan bemorlar uchun EsoGuard testlari orqali daromad keltiradi. Gastroenterologiyadagi yuqori narx belgilash imkoniyati saratonni erta tashxislashning muhimligi bilan bog'liqdir.

LUCD: Lucid Diagnostics, Inc Sof foyda normasi 04.07.2022 - 19.11.2026

Lucid Diagnostics Inc (LUCD) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- aksiya kursi va ekspertlarning narx prognozi:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning dastlabki tahlili:luciddx.com - LUCD
Lucid Diagnostics, Inc. yetakchi tovari

Investorlar xarajatlar inflyatsiyasiga nisbatan biznesning chidamliligini baholashlari kerak bo'lib, bunda xarajatlarni boshqarish samaradorligining asosiy ko'rsatkichi sifatida sof foyda marjasini tahlil qilish lozim. GURU.Markets platformasidagi sof foyda marjasining haqiqiy tendentsiyasi Lucid Diagnostics Inc. (LUCD) kompaniyasining klinika sherikliklari orqali EsoGuard testining joriy etilishini monetizatsiya qilish qobiliyatini aks ettiradi va bu vaqtincha operatsion xarajatlar bilan biznes modelining tizimli inqirozi o'rtasidagi farqni aniqlash imkonini beradi.

Lucid Diagnostics Inc. raqobatchilari

A (Agilent Technologies) - Sof foyda bo'yicha sotuv rentabelligi|DGX: Kompaniyaning sof rentabelligi|Sof marja Illumina Platform|EXAS (Exact Sciences) - Kompaniyaning sof rentabelligi|Sof foyda bo'yicha sotuv rentabelligi RVTY (PerkinElmer)|Bio-Rad - Sotuvning sof rentabelligi|Sotuvning sof marjinal rentabelligi NNNN (Anbio)|Sof foyda normasi SHC|QDEL - Sof marja|OPK: Sof marja|caredx.com (CDNA) - Sof marja|MRVI (Maravai LifeSciences) - Sof marja|FLGT (Fulgent) - Sotuvning sof marjinal rentabelligi|Standard BioTools Inc (LAB) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi CTKB|Sof foyda bo'yicha sotuv rentabelligi OraSure Technologies Inc OSUR|Sotuvning sof marjinal rentabelligi XGN (Exagen Diagnostics)|Sotuvning sof marjinal rentabelligi mdxhealth.com MDXH|prenetics.com - Sotuvning sof marjinal rentabelligi|Insight Molecular Diagnostics, Inc. (IMDX) - Sof foyda bo'yicha sotuv rentabelligi|TRIB: Sotuvning sof marjinal rentabelligi|ProPhase - Sof foyda normasi|Sof marja ainos.com|CODX: Sof foyda normasi|Sof marja HeartSciences (HSCS)|Sof foyda bo'yicha sotuv rentabelligi Biomerica Inc. BMRA|Sotuvning sof marjinal rentabelligi CDIO (Cardio Diagnostics)|ONCO - Sof foyda bo'yicha sotuv rentabelligi|VRAX: Sof foyda bo'yicha sotuv rentabelligi|bluejaydx.com (BJDX) - Sof foyda bo'yicha sotuv rentabelligi|AWH: Sotuvning sof marjinal rentabelligi|AXDX: Kompaniyaning sof rentabelligi|CNTG (CENTOGENE N.V.) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi Enzo Biochem, Inc. (ENZ)|FRES - Sof foyda marjasi|Genetic Technologies Limited (GENE) - Sof foyda bo'yicha marjinallik|Sotuvning sof marjinal rentabelligi ME (23andme.com)|Psychemedics Corp. (PMD) - Sof marja